Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
230 hedge funds and large institutions have $3.57B invested in Amicus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 91 increasing their positions, 64 reducing their positions, and 33 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 64
27% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 33
22% more call options, than puts
Call options by funds: $8.86M | Put options by funds: $7.25M
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more capital invested
Capital invested by funds: $3.2B → $3.57B (+$367M)
4% more funds holding
Funds holding: 222 → 230 (+8)
5.45% less ownership
Funds ownership: 109.55% → 104.1% (-5.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$55.7M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$13.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$11.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.51M |
| 5 |
Morgan Stanley
New York
|
+$7.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$179M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$19.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$19.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.2M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$16.5M |
FOLD Hedge Fund Activity: Q4 2022 in Review
230 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2022, worth a combined $3.57B — up 11% from $3.2B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new FOLD positions and 33 closed out — a net gain of 9 holders — while 91 added to existing stakes and 64 trimmed.
The largest buyer was Pictet Asset Management (Switzerland), adding an estimated $55.7M. The largest seller was Janus Henderson Group, cutting an estimated $179M.
- 230 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2022, up from 222 in Q3 2022.
- Funds reported $3.57B of Amicus Therapeutics stock for Q4 2022, up 11% quarter-over-quarter.
- 42 funds opened new Amicus Therapeutics positions in Q4 2022 and 33 closed out, a net change of +9 holders.
- The largest Amicus Therapeutics buyer in Q4 2022 was Pictet Asset Management (Switzerland), an estimated $55.7M added.
- The largest Amicus Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $179M sold.
Based on aggregated 13F filings for Q4 2022.